Cross-Clade Protective Immune Responses to Influenza Viruses with H5N1 HA and NA Elicited by an Influenza Virus-Like Particle H5N1 Influenza VLPs
Author Information
Author(s): Bright Rick A., Carter Donald M., Crevar Corey J., Toapanta Franklin R., Steckbeck Jonathan D., Cole Kelly S., Kumar Niranjan M., Pushko Peter, Smith Gale, Tumpey Terrence M., Ross Ted M.
Primary Institution: Novavax, Inc.
Hypothesis
Can a non-replicating virus-like particle (VLP) vaccine elicit a cross-clade protective immune response against H5N1 influenza viruses?
Conclusion
The study demonstrates that a non-replicating virus-like particle vaccine is effective at eliciting a broad, cross-clade protective immune response against H5N1 influenza viruses.
Supporting Evidence
- Mice vaccinated with VLPs were protected against lethal viral challenges.
- VLPs elicited both humoral and cellular immune responses.
- Protection was independent of pre-challenge HAI titer or cell-mediated responses.
Takeaway
Researchers created a new type of flu vaccine that helps protect against different kinds of H5N1 flu viruses, even if they are not exactly the same as the vaccine.
Methodology
Mice were vaccinated with either a one-dose or two-dose regimen of VLPs, and immune responses were compared to those induced by recombinant hemagglutinin (rHA).
Limitations
The study was conducted in mice, and results may not directly translate to humans.
Participant Demographics
BALB/c mice, females, 6–8 weeks of age.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website